These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6518833)

  • 1. Serum concentrations of metronidazole and its main metabolite in patients with active Crohn's disease: correlation with disease activity and therapeutic efficacy?
    Schneider MU; Riemann JF; Laudage G
    Chemotherapy; 1984; 30(6):345-52. PubMed ID: 6518833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of Crohn's disease with metronidazole -- an uncontrolled trial --.
    Kasper H; Sommer H; Kühn HA
    Acta Hepatogastroenterol (Stuttg); 1979 Jun; 26(3):217-21. PubMed ID: 573534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result.
    Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O; Rosén A
    Gastroenterology; 1982 Sep; 83(3):550-62. PubMed ID: 6124474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metronidazole therapy for Crohn's disease and associated fistulae.
    Jakobovits J; Schuster MM
    Am J Gastroenterol; 1984 Jul; 79(7):533-40. PubMed ID: 6741906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double blind, placebo controlled trial of metronidazole in Crohn's disease.
    Sutherland L; Singleton J; Sessions J; Hanauer S; Krawitt E; Rankin G; Summers R; Mekhjian H; Greenberger N; Kelly M
    Gut; 1991 Sep; 32(9):1071-5. PubMed ID: 1916494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin.
    Prantera C; Berto E; Scribano ML; Falasco G
    Ital J Gastroenterol Hepatol; 1998 Dec; 30(6):602-6. PubMed ID: 10076781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metronidazole for Crohn's disease.
    Ursing B; Kamme C
    Lancet; 1975 Apr; 1(7910):775-7. PubMed ID: 48003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between concentrations of metronidazole and Bacteroides spp in faeces of patients with Crohn's disease and healthy individuals.
    Krook A; Lindström B; Kjellander J; Järnerot G; Bodin L
    J Clin Pathol; 1981 Jun; 34(6):645-50. PubMed ID: 7251906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effect of metronidazole and sulfasalazine on Crohn's disease in relation to changes in the fecal flora.
    Krook A; Järnerot G; Danielsson D
    Scand J Gastroenterol; 1981; 16(4):569-75. PubMed ID: 6119763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steady-state pharmacokinetics of metronidazole in Crohn's disease.
    Eradiri O; Jamali F; Thomson AB
    Biopharm Drug Dispos; 1987; 8(3):249-59. PubMed ID: 3593902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of topical metronidazole (10 percent) in the treatment of anorectal Crohn's disease.
    Stringer EE; Nicholson TJ; Armstrong D
    Dis Colon Rectum; 2005 May; 48(5):970-4. PubMed ID: 15785894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of Crohn's disease with metronidazole or its derivatives].
    Laverdant C; Molinie C; Essioux H; Daly JP; Braillon A; Vergeau JP; Flechaire A
    Med Chir Dig; 1982; 11(5):315-9. PubMed ID: 7144278
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum calprotectin as a biomarker for Crohn's disease.
    Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E;
    J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The course of Crohn disease and side effect profile with long-term treatment using metronidazole].
    Gugler R; Jensen JC; Schulte H; Vogel R
    Z Gastroenterol; 1989 Nov; 27(11):676-82. PubMed ID: 2515668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of topical metronidazole in the treatment of anorectal Crohn's disease.
    McElhiney LF
    Int J Pharm Compd; 2013; 17(5):380-3. PubMed ID: 24459783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term management of Crohn's disease with mesalamine capsules (Pentasa). Pentasa Crohn's Disease Compassionate Use Study Group.
    Hanauer SB; Krawitt EL; Robinson M; Rick GG; Safdi MA
    Am J Gastroenterol; 1993 Sep; 88(9):1343-51. PubMed ID: 8362827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metronidazole in the treatment of Crohn disease. Results of a controlled randomized prospective study].
    Schneider MU; Laudage G; Guggenmoos-Holzmann I; Riemann JF
    Dtsch Med Wochenschr; 1985 Nov; 110(45):1724-30. PubMed ID: 2865120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and skin blister fluid concentrations of metronidazole and its hydroxy metabolite after oral administration.
    Klimowicz A; Nowak A; Bielecka-Grzela S
    Pol J Pharmacol; 1996; 48(1):47-52. PubMed ID: 9112627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the fecal flora of patients with Crohn's disease during treatment with metronidazole. A preliminary report.
    Krook A; Danielsson D; Kjellander J; Järnerot G
    Scand J Gastroenterol; 1979; 14(6):705-10. PubMed ID: 231297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease.
    Dotan I; Rachmilewitz D; Schreiber S; Eliakim R; van der Woude CJ; Kornbluth A; Buchman AL; Bar-Meir S; Bokemeyer B; Goldin E; Maaser C; Mahadevan U; Seidler U; Hoffman JC; Homoky D; Plasse T; Powers B; Rutgeerts P; Hommes D;
    Gut; 2010 Jun; 59(6):760-6. PubMed ID: 20551461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.